STABL — Stayble Therapeutics AB Balance Sheet
0.000.00%
Last trade - 00:00- SEK14.29m
- SEK9.49m
Annual balance sheet for Stayble Therapeutics AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | SAS | SAS | SAS | SAS | SAS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Short Term Investments | 10.9 | 37.5 | 12.8 | 14.1 | 2.2 |
| Net Total Receivables | 0.274 | 0.325 | 0.318 | 0.252 | 0.128 |
| Prepaid Expenses | |||||
| Total Current Assets | 12.3 | 38 | 13.5 | 16.1 | 3.61 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Total Assets | 18 | 43.6 | 19.1 | 21.7 | 9.26 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 1.4 | 2.98 | 3.02 | 4.34 | 1.53 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Liabilities | 2.45 | 3.83 | 3.87 | 5.19 | 2.38 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 15.5 | 39.8 | 15.3 | 16.5 | 6.87 |
| Total Liabilities & Shareholders' Equity | 18 | 43.6 | 19.1 | 21.7 | 9.26 |
| Total Common Shares Outstanding |